DODB

DODB, also known as 2,5-dimethoxy-4,6-dibromoamphetamine or as 6-bromo-DOB, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOB.^[1] It is the 6-bromo derivative of DOB and the 4,6-dibromo derivative of 2,5-dimethoxyamphetamine (2,5-DMA; DOH).^[1] The drug has a dose range of 5 to 8 mg orally and a duration of 12 to 20 hours.^[1] For comparison, DOB has a dose of 1 to 3 mg and a duration of 18 to 30 hours.^[1] DODB is described as having largely the same effects as DOB.^[1] However, it is said that the drug may have somewhat greater visual effects than DOB and that its physical side effects appear to be less pronounced than those of DOB.^[1] DODB was synthesized and tested by P. Rausch in the 1990s or 2000s.^[1][2] It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information.^[1]

DODB

Clinical data
Other names	6-Bromo-DOB; 2,5-Dimethoxy-4,6-dibromoamphetamine; 2,4-Dibromo-3,6-dimethoxyamphetamine
Routes of administration	Oral[1]
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None
Pharmacokinetic data
Duration of action	12–20 hours[1]
Identifiers
IUPAC name 1-(2,4-dibromo-3,6-dimethoxyphenyl)propan-2-amine
Chemical and physical data
Formula	C11H15Br2NO2
Molar mass	353.054 g·mol−1
3D model (JSmol)	Interactive image
SMILES COc1c(Br)cc(c(c1Br)CC(N)C)OC
InChI InChI=1S/C11H15Br2NO2/c1-6(14)4-7-9(15-2)5-8(12)11(16-3)10(7)13/h5-6H,4,14H2,1-3H3 Key:MFEJTCMFVXAELO-UHFFFAOYSA-N

See also

• DOx (psychedelics)
• 2C-DB
• DODC
• 2-Bromomescaline
• 2-Bromo-TMA